Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B2WK
|
||||
Former ID |
DCL000275
|
||||
Drug Name |
Ifetroban sodium
|
||||
Synonyms |
Ifetroban sodium [USAN]; BMS-180291 sodium salt; BMS-180291-02
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Phase 2 | [539284] | ||
Company |
Bristol-Myers Squibb
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H32N2O5
|
||||
InChI |
InChI=1S/C25H32N2O5/c1-2-3-6-13-26-24(30)19-15-31-25(27-19)23-18(20-10-11-21(23)32-20)14-17-8-5-4-7-16(17)9-12-22(28)29/h4-5,7-8,15,18,20-21,23H,2-3,6,9-14H2,1H3,(H,26,30)(H,28,29)/t18-,20-,21+,23-/m0/s1
|
||||
InChIKey |
BBPRUNPUJIUXSE-DXKRWKNPSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Antagonist | [536029] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.